Regulatory authorities around the world are producing carefully worded notices in reaction to the discovery by Singapore’s Health Sciences Agency of a genotoxic nitrosamine impurity in a few formulations of the diabetes treatment metformin.
This marks the third chronic health condition long treated with medications now found to contain traces of the probable carcinogens,...





